The Incidence and Risk Factors for Adverse Drug Reactions Related to Tanreqing Injection: A Large Population-Based Study in China
Background: Tanreqing injection (TRQ) is a traditional Chinese medicine commonly used in China to treat pulmonary diseases presenting as phlegm-heat syndrome. Robust data on the safety of TRQ from real-world observational cohorts are currently lacking.Objective: To evaluate as the incidence, type, a...
Saved in:
Main Authors: | Xiao-Xiao Li (Author), Lin Zhuo (Author), Yan Zhang (Author), Yi-Heng Yang (Author), Hong Zhang (Author), Si-Yan Zhan (Author), Suo-Di Zhai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis
by: Xiao-xiao Li, et al.
Published: (2021) -
Pharmacokinetic study of the main components of Tanreqing capsules and Tanreqing injections in beagles by liquid chromatography-tandem mass spectrometry
by: Lili Cui, et al.
Published: (2022) -
Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis
by: Zhan-Miao Yi, et al.
Published: (2020) -
Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease
by: Zhan-Miao Yi, et al.
Published: (2022) -
Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome
by: Hefei Huang, et al.
Published: (2024)